7XT4
Structure of Craspase-NTR
Summary for 7XT4
Entry DOI | 10.2210/pdb7xt4/pdb |
EMDB information | 33439 |
Descriptor | CHAT domain protein, RNA (5'-R(P*GP*GP*GP*GP*CP*AP*GP*AP*AP*AP*AP*UP*UP*GP*GP*GP*UP*AP*CP*CP*G)-3'), RAMP superfamily protein, ... (5 entities in total) |
Functional Keywords | immune system-rna complex, immune system/rna |
Biological source | Candidatus Scalindua brodae More |
Total number of polymer chains | 4 |
Total formula weight | 313370.89 |
Authors | |
Primary citation | Liu, X.,Zhang, L.,Wang, H.,Xiu, Y.,Huang, L.,Gao, Z.,Li, N.,Li, F.,Xiong, W.,Gao, T.,Zhang, Y.,Yang, M.,Feng, Y. Target RNA activates the protease activity of Craspase to confer antiviral defense. Mol.Cell, 82:4503-4518.e8, 2022 Cited by PubMed Abstract: In the type III-E CRISPR-Cas system, a Cas effector (gRAMP) is associated with a TPR-CHAT to form Craspase (CRISPR-guided caspase). However, both the structural features of gRAMP and the immunity mechanism remain unknown for this system. Here, we report structures of gRAMP-crRNA and gRAMP:cRNA:target RNA as well as structures of Craspase and Craspase complexed with cognate target RNA (CTR) or non-cognate target RNA (NTR). Importantly, the 3' anti-tag region of NTR and CTR binds at two distinct channels in Craspase, and CTR with a non-complementary 3' anti-tag induces a marked conformational change of the TPR-CHAT, which allosterically activates its protease activity to cleave an ancillary protein Csx30. This cleavage then triggers an abortive infection as the antiviral strategy of the type III-E system. Together, our study provides crucial insights into both the catalytic mechanism of the gRAMP and the immunity mechanism of the type III-E system. PubMed: 36306795DOI: 10.1016/j.molcel.2022.10.007 PDB entries with the same primary citation |
Experimental method | ELECTRON MICROSCOPY (3.08 Å) |
Structure validation
Download full validation report
